OBJECTIVE: To evaluate the antihyperglycemic activity of leaves of Hyptis suaveolens using streptozotocin model. METHODS: Hyptis suaveolens extract (HSE) 250 and 500 mg/kg body weight was administered orally to streptozotocin induced diabetes, once daily for 21 days. RESULTS: A significant reduction in blood glucose was observed in diabetic animals treated with HSE at different doses when compared with diabetic rats. Levels of triglyceride, total cholesterol, low density lipoprotein, very low density lipoprotein were decreased while administering HSE at different doses, compared with their control values in diabetic animals. CONCLUSIONS: Our results show that HSE possesses significant antihyperglycemic activity which might be attributed to stimulating effects on glucose utilization and antioxidant enzyme.
OBJECTIVE: To evaluate the antihyperglycemic activity of leaves of Hyptis suaveolens using streptozotocin model. METHODS:Hyptis suaveolens extract (HSE) 250 and 500 mg/kg body weight was administered orally to streptozotocin induced diabetes, once daily for 21 days. RESULTS: A significant reduction in blood glucose was observed in diabetic animals treated with HSE at different doses when compared with diabeticrats. Levels of triglyceride, total cholesterol, low density lipoprotein, very low density lipoprotein were decreased while administering HSE at different doses, compared with their control values in diabetic animals. CONCLUSIONS: Our results show that HSE possesses significant antihyperglycemic activity which might be attributed to stimulating effects on glucose utilization and antioxidant enzyme.
Authors: Michael Buenor Adinortey; Rosemary Agbeko; Daniel Boison; William Ekloh; Lydia Enyonam Kuatsienu; Emmanuel Ekow Biney; Obed O Affum; Jeffery Kwarteng; Alexander Kwadwo Nyarko Journal: Evid Based Complement Alternat Med Date: 2019-04-18 Impact factor: 2.629